Advanced search
Publication Cover
Future Oncology Volume 8, 2012 - Issue 12
Submit an article Journal homepage
473
Views
0
CrossRef citations to date
0
Altmetric
Priority Paper Evaluation

Significance of Serum DKK1 as a Diagnostic Biomarker in Hepatocellular Carcinoma

Edmund Kwok-Kwan Tung1 Department of Pathology & State Key Laboratory for Liver Research, The University of Hong Kong, Pokfulam, Hong KongView further author information
&
Irene Oi-Lin Ng1 Department of Pathology & State Key Laboratory for Liver Research, The University of Hong Kong, Pokfulam, Hong Kong;1 Department of Pathology & State Key Laboratory for Liver Research, The University of Hong Kong, Pokfulam, Hong Kong. [email protected]Correspondence[email protected]
View further author information
Pages 1525-1528 | Published online: 12 Dec 2012

References

  • Shen Q , FanJ, YangXRet al. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. Lancet Oncol. 13(8), 817–826 (2012).
  • Ferlay J , ShinHR, BrayF, FormanD, MathersC, ParkinDM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.Int. J. Cancer127(12), 2893–2917 (2010).
  • Jemal A , BrayF, CenterMM, FerlayJ, WardE, FormanD. Global cancer statistics.CA: Cancer J. Clin.61(2), 69–90 (2011).
  • Bae JS , ParkSJ, ParkKBet al. Acute exacerbation of hepatitis in liver cirrhosis with very high levels of α-fetoprotein but no occurrence of hepatocellular carcinoma. Korean J. Int. Med. 20(1), 80–85 (2005).
  • Soresi M , MagliarisiC, CampagnaPet al. Usefulness of α-fetoprotein in the diagnosis of hepatocellular carcinoma. Anticancer Res. 23(2C), 1747–1753 (2003).
  • Khien VV , MaoHV, ChinhTTet al. Clinical evaluation of lentil lectin-reactive α-fetoprotein-L3 in histology-proven hepatocellular carcinoma. Int. J. Biol. Markers 16(2), 105–111 (2001).
  • Sengupta B , SiddiqiSA. Hepatocellular carcinoma: important biomarkers and their significance in molecular diagnostics and therapy.Curr. Med. Chem.19(22), 3722–3729 (2012).
  • Malaguarnera G , GiordanoM, PaladinaI, BerrettaM, CappellaniA, MalaguarneraM. Serum markers of hepatocellular carcinoma.Dig. Dis. Sci.55(10), 2744–2755 (2010).
  • Mann CD , NealCP, GarceaG, MansonMM, DennisonAR, BerryDP. Prognostic molecular markers in hepatocellular carcinoma: a systematic review.Eur. J. Cancer43(6), 979–992 (2007).
  • Spangenberg HC , ThimmeR, BlumHE. Serum markers of hepatocellular carcinoma.Semin. Liver Dis.26(4), 385–390 (2006).
  • Cui R , HeJ, ZhangFet al. Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum γ-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to α-fetoprotein. Br. J. Cancer 88(12), 1878–1882 (2003).
  • Hippo Y , WatanabeK, WatanabeAet al. Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma. Cancer Res. 64(7), 2418–2423 (2004).
  • Shimizu A , ShirakiK, ItoTet al. Sequential fluctuation pattern of serum des-γ-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis. Int. J. Mol. Med. 9(3), 245–250 (2002).
  • Zender L , KubickaS. Molecular pathogenesis and targeted therapy of hepatocellular carcinoma.Onkologie31(10), 550–555 (2008).
  • Wong CM , NgIO. Molecular pathogenesis of hepatocellular carcinoma.Liver Int.28(2), 160–174 (2008).
  • Takigawa Y , BrownAM. Wnt signaling in liver cancer.Curr. Drug Targets9(11), 1013–1024 (2008).
  • Tung EK , MakCK, FatimaSet al. Clinicopathological and prognostic significance of serum and tissue Dickkopf-1 levels in human hepatocellular carcinoma. Liver Int. 31(10), 1494–1504 (2011).
  • Sato N , YamabukiT, TakanoAet al. Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy. Cancer Res. 70(13), 5326–5336 (2010).
  • Yu B , YangX, XuYet al. Elevated expression of DKK1 is associated with cytoplasmic/nuclear β-catenin accumulation and poor prognosis in hepatocellular carcinomas. J. Hepatol. 50(5), 948–957 (2009).
  • Gonzalez-Sancho JM , AguileraO, GarciaJMet al. The Wnt antagonist DICKKOPF-1 gene is a downstream target of β-catenin/TCF and is downregulated in human colon cancer. Oncogene 24(6), 1098–1103 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.